Gironde

我们是谁

• 4 月 5, 2022

  BMS-986288单独或与Nivolumab联合治疗晚期实体瘤的免疫疗法研究

• 4 月 5, 2022

  A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid Tumors